help button home button Am J Pathol ASIP WHAT IS IT?
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Originally published online as doi:10.2353/ajpath.2008.071128 on August 7, 2008

Published online before print August 7, 2008
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Material
Right arrow All Versions of this Article:
ajpath.2008.071128v1
173/3/700    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Hull, M. L.
Right arrow Articles by Charnock-Jones, D. S.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hull, M. L.
Right arrow Articles by Charnock-Jones, D. S.
(American Journal of Pathology. 2008;173:700-715.)
© 2008 American Society for Investigative Pathology
DOI: 10.2353/ajpath.2008.071128

Endometrial-Peritoneal Interactions during Endometriotic Lesion Establishment

M. Louise Hull*{dagger}, Claudia Rangel Escareno{ddagger}§, Jane M. Godsland*, John R. Doig, Claire M. Johnson||, Stephen C. Phillips||, Stephen K. Smith**{dagger}{dagger}, Simon Tavaré{ddagger}{ddagger}{ddagger}, Cristin G. Print*§§ and D. Stephen Charnock-Jones*{dagger}{dagger}

From the Departments of Pathology,* and Obstetrics and Gynaecology,{dagger}{dagger} University of Cambridge, Cambridge, United Kingdom; the Research Centre for Reproductive Health,{dagger} University of Adelaide, South Australia, Australia; the Program in Molecular and Computational Biology,{ddagger} University of Southern California, Los Angeles, California; the National Institute of Genomic Medicine,§ México City, México; The Oxford Clinic, Christchurch, New Zealand; Pfizer Central Research,|| Sandwich, Kent, United Kingdom; the Faculty of Medicine Centre,** Imperial College London, London, United Kingdom; the Department of Oncology,{ddagger}{ddagger} University of Cambridge Li Ka Shing Centre, Cambridge, United Kingdom; and the Department of Molecular Medicine and Pathology,§§ University of Auckland, Auckland, New Zealand

The pathophysiology of endometriosis remains unclear but involves a complex interaction between ectopic endometrium and host peritoneal tissues. We hypothesized that disruption of this interaction would suppress endometriotic lesion formation. We hoped to delineate the molecular and cellular dialogue between ectopic human endometrium and peritoneal tissues in nude mice as a first step toward testing this hypothesis. Human endometrium was xenografted into nude mice, and the resulting lesions were analyzed using microarrays. A novel technique was developed that unambiguously determined whether RNA transcripts identified via microarray analyses originated from human cells (endometrium) or mouse cells (mesothelium). Four key pathways (ubiquitin/proteasome, inflammation, tissue remodeling/repair, and ras-mediated oncogenesis) were revealed, demonstrating communication between host mesothelial cells and ectopic endometrium. Morphometric analysis of nude mouse lesions confirmed that necrosis, inflammation, healing and repair, and cell proliferation occurred during xenograft development. These processes were entirely consistent with the molecular networks revealed by the microarray data. The transcripts detected in the xenografts overlapped with differentially expressed transcripts in a comparison between paired eutopic and ectopic endometria from human endometriotic patients. For the first time, components of the interaction between ectopic endometrium and peritoneal stromal tissues are revealed. Targeted disruption of this dialogue is likely to inhibit endometriotic tissue formation and may prove to be an effective therapeutic strategy for endometriosis.








HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the American Society for Investigative Pathology.